| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | -72.2% |
| R&D Expense | $77.0M | -0.8% |
| SG&A Expense | $63.1M | +26.5% |
| Operating Income | -$139.2M | -12.2% |
| Pre-tax Income | -$130.9M | -10.7% |
| Income Tax | $0 | +100.0% |
| Net Income | -$130.9M | -11.7% |
| EPS (Basic) | -$6.62 | -470.7% |
| EPS (Diluted) | -$6.62 | -470.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.7M | -19.1% |
| Short-term Investments | $65.0M | +202.1% |
| Current Assets | $131.3M | +27.8% |
| Total Assets | $179.8M | +3.9% |
| Current Liabilities | $22.9M | -8.1% |
| Total Liabilities | $109.1M | +21.9% |
| Stockholders' Equity | $70.7M | -15.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$92.5M | -1.7% |
| Capital Expenditures | $388K | -52.0% |
| Investing Cash Flow | -$41.9M | -143.2% |
| Financing Cash Flow | $120.0M | — |
| Free Cash Flow | -$92.8M | -1.2% |